LRCXTICKER
Lam Research Corp.
Congress has disclosed 35 buys and 36 sells of LRCX (Lam Research Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
35
Buy
36
Sell
-1
Net
19
Active politicians
Round-trip watch Still on the books
Members who disclosed buying LRCX and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Cleo Fields | 2026-02-03 | $229.42 | $239.11 | +4.2% | ↩ near entry |
| Marjorie Taylor Greene | 2025-04-04 | $58.56 | $239.11 | +308.3% | in profit |
| Jefferson Shreve | 2025-03-31 | $72.04 | $239.11 | +231.9% | in profit |
| Byron Donalds | 2025-08-07 | $98.50 | $239.11 | +142.8% | in profit |
| Jonathan Jackson | 2025-08-13 | $106.04 | $239.11 | +125.5% | in profit |
| Rohit Khanna | 2026-03-30 | $199.58 | $239.11 | +19.8% | in profit |
| Alan Armstrong | 2026-03-30 | $199.58 | $239.11 | +19.8% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2027 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Industrials. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
35.35
▲ pricier than
Industrials (median 24.6)
how it's calculated
P/E = price ÷ earnings per share
$239.11 ÷ $6.76 = 35.35
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
21.48
▲ pricier than
Industrials (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$239.11 ÷ $11.13 = 21.48
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
29.22
▲ pricier than
Industrials (median 15.0)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA — net cash lowers EV
($298.7B − $3.7B net cash) ÷ $10.1B = $295.0B ÷ $10.1B = 29.22
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
71 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| David Taylor | House | BUY ◆ insider divergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-10-15 | 14 days | -8.3% | $1K–$15K 0.3% of NW |
65.9 | ↗ filing |
| Sheldon Whitehouse | Senate | SELL ◆ insider convergence | Spouse | 2026-08-13 | 20 days | -14.4% | $1K–$15K | 96.3 | ↗ eFD |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-06-05 | 6 days | +19.5% | $1K–$15K 0.3% of NW |
7.5 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-04-27 | 4 days | -1.1% | $1K–$15K 0.3% of NW |
4.0 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2026-04-27 | 4 days | -1.1% | $1K–$15K 0.3% of NW |
4.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2026-03-30 | 3 days | +9.3% | $1K–$15K | 48.8 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-30 | 113 days | +61.2% | $1K–$15K | 60.5 | ↗ eFD |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | +52.4% | $1K–$15K | 93.9 | ↗ eFD |
| David Taylor | House | BUY ◆ insider divergence · moderate | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-03-12 | 7 days | +11.7% | $1K–$15K 0.3% of NW |
18.8 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2026-02-26 | 7 days | -10.1% | $1K–$15K 0.3% of NW |
4.1 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-02-26 | 7 days | -10.1% | $1K–$15K 0.3% of NW |
4.1 | ↗ filing |
| Cleo Fields | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley - E*TRADE #2 | 2026-02-03 | 0 days | 0.0% | $15K–$50K 0.1% of NW |
69.7 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2026-01-16 | 14 days | +4.7% | $1K–$15K 0.3% of NW |
4.9 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence · moderate | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2026-01-08 | 7 days | +8.2% | $15K–$50K 1.2% of NW |
28.3 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
46.9 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2025-09-22 | 11 days | +10.5% | $1K–$15K 0.3% of NW |
32.4 | ↗ filing |
| David Taylor | House | SELL ◆ insider convergence | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2025-09-22 | 11 days | +10.5% | $1K–$15K 0.3% of NW |
32.4 | ↗ filing |
| Jonathan Jackson | House | SELL ◆ insider convergence | Spouse · Morgan Stanley - Rollover IRA | 2025-09-03 | 33 days | +52.9% | $1K–$15K 0.3% of NW |
32.3 | ↗ filing |
| Jonathan Jackson | House | BUY | Spouse · Morgan Stanley - Rollover IRA | 2025-08-13 | 21 days | -8.4% | $1K–$15K 0.3% of NW |
33.9 | ↗ filing |
| Byron Donalds | House | BUY | Spouse · Moran Wealth IRA | 2025-08-07 | 25 days | +1.0% | $1K–$15K 0.3% of NW |
67.4 | ↗ filing |
| Byron Donalds | House | BUY | Self · Moran Wealth IRA | 2025-08-07 | 25 days | +1.0% | $1K–$15K 0.3% of NW |
67.4 | ↗ filing |
| David Taylor | House | SELL | Self · David Taylor Trust > Sardinia Ready Mix 401(k) - Dave | 2025-07-18 | 13 days | -5.8% | $1K–$15K 0.3% of NW |
64.7 | ↗ filing |
| David Taylor | House | SELL | Self · David Taylor Trust > Schwab Joint Brokerage #1 (Home Grown) | 2025-07-18 | 13 days | -5.8% | $1K–$15K 0.3% of NW |
64.7 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider divergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
33.6 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider divergence · moderate | Joint · Merrill Lynch Long Term Growth | 2025-04-07 | 29 days | +17.6% | $1K–$15K <0.1% of NW |
66.4 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider convergence · moderate | Self | 2025-04-04 | 3 days | +5.3% | $1K–$15K | 33.6 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider convergence · moderate | Self · CRT - Standard Unit Trust | 2025-03-31 | 3 days | -10.3% | $50K–$100K <0.1% of NW |
93.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2025-03-12 | 26 days | -18.8% | $15K–$50K | 60.1 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2025-02-04 | 219 days | +45.4% | $1K–$15K 0.8% of NW |
48.9 | ↗ filing |
| William Keating | House | SELL ◆ insider convergence | Self · Bill's IRA | 2025-01-24 | 31 days | +4.6% | $1K–$15K 0.3% of NW |
25.3 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence | Self · JP Morgan Brokerage Account #2 | 2025-01-16 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2024-11-25 | 1 days | -1.4% | $1K–$15K | 50.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-11-15 | 19 days | +11.7% | $1K–$15K | 59.5 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider divergence | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | +48.9% | $1K–$15K 0.8% of NW |
84.9 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-10-22 | 14 days | +4.7% | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-10-17 | 19 days | +4.5% | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2024-10-04 | 3 days | -1.1% | $1K–$15K | 59.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-09-23 | 10 days | +3.3% | $1K–$15K <0.1% of NW |
5.9 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2024-09-20 | 3 days | +1.4% | $1K–$15K | 86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-09-09 | 23 days | +11.1% | $1K–$15K | 86.8 | ↗ filing |
| John James | House | SELL ◆ insider convergence | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -1.1% | $1K–$15K <0.1% of NW |
33.0 | ↗ filing |
| John James | House | SELL ◆ insider convergence | Self · John A. James Children’s Trust | 2024-07-30 | 28 days | — | $1K–$15K <0.1% of NW |
62.4 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
0.3 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-01-25 | 13 days | — | $1K–$15K <0.1% of NW |
6.2 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence | Spouse · MV Capital - GST Exempt Trust #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
0.8 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-01-23 | 10 days | — | $15K–$50K 0.3% of NW |
14.0 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
0.8 | ↗ filing |
| Jonathan Jackson | House | BUY ◆ insider divergence | Joint · Morgan Stanley Trust Account | 2024-01-19 | 17 days | — | $15K–$50K 1.1% of NW |
89.2 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence | Joint · Northwestern Mutual - Joint | 2023-12-04 | 0 days | — | $1K–$15K | 15.7 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence · moderate | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
75.9 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence · moderate | Joint · Northwestern Mutual - Joint | 2023-06-21 | 26 days | — | $1K–$15K | 22.3 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider divergence | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2023-04-28 | 4 days | — | $1K–$15K 0.1% of NW |
8.6 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-02-14 | 21 days | — | $1K–$15K <0.1% of NW |
14.1 | ↗ filing |
| William Keating | House | BUY ◆ insider divergence | Self · Bill's IRA | 2023-02-13 | 15 days | — | $1K–$15K 0.3% of NW |
52.4 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-01-11 | 26 days | — | $1K–$15K <0.1% of NW |
6.8 | ↗ filing |
| Kathy Manning | House | SELL | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-10-12 | 23 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Kathy Manning | House | BUY | Self · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2022-07-27 | 7 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2022-01-26 | 12 days | — | $1K–$15K <0.1% of NW |
8.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-11-08 | 28 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-10-29 | 6 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| John Curtis | House | SELL | Self | 2021-06-22 | 9 days | — | $1K–$15K | 40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2021-06-09 | 33 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Kathy Manning | House | BUY | Self | 2021-04-30 | 6 days | — | $15K–$50K 0.3% of NW |
94.9 | ↗ filing |
| Kathy Manning | House | BUY | Spouse | 2021-04-30 | 6 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Deborah Ross | House | BUY | Spouse | 2021-04-27 | 0 days | — | $15K–$50K 0.6% of NW |
95.4 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-03-31 | 7 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| William Keating | House | BUY | Self | 2021-03-17 | 9 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| John Curtis | House | BUY | Self | 2020-03-27 | 0 days | — | $1K–$15K | 86.8 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2020-02-28 | 7 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in LRCX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
29
Congress trades with insider convergence
22
…with insider divergence
187
Insider open-market trades
Of the congressional trades in LRCX, 29 coincided with corporate insiders moving the same way within 60 days, and 22 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-11-02 | Mayer Bethany | Director | SELL 10b5-1 | $174K | ↗ EDGAR |
| 2026-10-23 | ARCHER TIMOTHY | C-suite | SELL 10b5-1 | $7.1M | ↗ EDGAR |
| 2026-09-09 | ARCHER TIMOTHY | C-suite | SELL 10b5-1 | $9.6M | ↗ EDGAR |
| 2026-09-09 | Mayer Bethany | Director | SELL | $3.0M | ↗ EDGAR |
| 2026-09-02 | Varadarajan Seshasayee | Other | SELL 10b5-1 | $5.8M | ↗ EDGAR |
| 2026-09-02 | Varadarajan Seshasayee | Other | SELL 10b5-1 | $3.6M | ↗ EDGAR |
| 2026-09-02 | Varadarajan Seshasayee | Other | SELL 10b5-1 | $8.0M | ↗ EDGAR |
| 2026-08-31 | Harter Ava | C-suite | SELL 10b5-1 | $1.5M | ↗ EDGAR |
| 2026-08-06 | ARCHER TIMOTHY | C-suite | SELL 10b5-1 | $9.0M | ↗ EDGAR |
| 2026-07-13 | TALWALKAR ABHIJIT Y | Director | SELL 10b5-1 | $6.1M | ↗ EDGAR |
| 2026-07-02 | ARCHER TIMOTHY | C-suite | SELL 10b5-1 | $11.7M | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $107K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $498K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $394K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $1.4M | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $686K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $296K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $981K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $852K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $838K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $438K | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $2.1M | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $1.5M | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $1.5M | ↗ EDGAR |
| 2026-06-12 | BRANDT ERIC | Director | SELL 10b5-1 | $1.9M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-11-02 | Mayer Bethany Director 10b5-1 | SELL | $174K |
| ◆ insider | 2026-10-23 | ARCHER TIMOTHY C-suite 10b5-1 | SELL | $7.1M |
| Congress | 2026-10-15 | David Taylor | BUY | $1K–$15K |
| ◆ insider | 2026-09-09 | ARCHER TIMOTHY C-suite 10b5-1 | SELL | $9.6M |
| ◆ insider | 2026-09-09 | Mayer Bethany Director | SELL | $3.0M |
| ◆ insider | 2026-09-02 | Varadarajan Seshasayee Other 10b5-1 | SELL | $5.8M |
| ◆ insider | 2026-09-02 | Varadarajan Seshasayee Other 10b5-1 | SELL | $3.6M |
| ◆ insider | 2026-09-02 | Varadarajan Seshasayee Other 10b5-1 | SELL | $8.0M |
| ◆ insider | 2026-08-31 | Harter Ava C-suite 10b5-1 | SELL | $1.5M |
| Congress | 2026-08-13 | Sheldon Whitehouse | SELL | $1K–$15K |
| ◆ insider | 2026-08-06 | ARCHER TIMOTHY C-suite 10b5-1 | SELL | $9.0M |
| ◆ insider | 2026-07-13 | TALWALKAR ABHIJIT Y Director 10b5-1 | SELL | $6.1M |
| ◆ insider | 2026-07-02 | ARCHER TIMOTHY C-suite 10b5-1 | SELL | $11.7M |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $107K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $498K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $394K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $1.4M |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $686K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $296K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $981K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $852K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $838K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $438K |
| ◆ insider | 2026-06-12 | BRANDT ERIC Director 10b5-1 | SELL | $2.1M |
FAQ Common questions
How much has Congress traded LRCX?
35 disclosed buys and 36 sells of LRCX (Lam Research Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade LRCX?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.